North American Cannabis Holdings and Puration Take Next Step to Expand Reach Into $57 Billion Legal Cannabis Market

DALLAS, June 26, 2018 /PRNewswire/ --

North American Cannabis Holdings, Inc. (USOTC: USMJ) and Puration, Inc. (USOTC: PURA) today announced a substantial milestone in their recently disclosed strategy to expand their reach into the worldwide legal cannabis market expected to reach $57 billion in annual sales within the next ten years. The strategic plan detailed online is designed to capitalize on the two company's successes with EVERx CBD Infused Sports Water and the AmeriCanna Cafe and to build momentum behind their new cannabis cultivation and ecommerce businesses. The strategic plan presentation is available in its entirety on the company website. The milestone reached today entails both USMJ and PURA entering into respective agreements with two independently listed companies to facilitate the spinoff and dividends included in the overall strategic plan to expand their reach into the worldwide legal cannabis market. The company's plan to release a letter to shareholders aftermarket this Friday, June 29^th with more details on the spinoff milestone announced today. To receive an email of the shareholder letter, sign up on the company's website.

For more information visit http://www.aciconglomerated.com.

Disclaimer/Safe Harbor: 
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Steven Rash
info@aciconglomerated.com
+1-800-861-1350

SOURCE North American Cannabis Holdings, Inc. and Puration, Inc.